Biogen to Present at Bank of America Merrill Lynch Global Healthcare Conference London

CAMBRIDGE, Mass.--()--Biogen Inc. (NASDAQ: BIIB) announced today that it will present at Bank of America Merrill Lynch Global Healthcare Conference London. The webcast will be live on Friday, September 18, 2015 at 10:40 a.m. BST (5:40 a.m. ET.) To access the live webcast, please visit Biogen’s Investors section at www.biogen.com. An archived version of the webcast will be available for 14 days following the presentation.

About Biogen

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For product labeling, press releases and additional information about the company, please visit www.biogen.com.

Contacts

Biogen
Karen Jewell, 781-464-2442
Investor Relations

Recent Stories

RSS feed for Biogen Inc.

Release Summary

Biogen to Present at Bank of America Merrill Lynch Global Healthcare Conference London

Biogen Inc.